Overview

Nucleic Acid Isolation and Purification Market is poised to value over USD 5.4 billion by 2027 end at a CAGR of over 8.9% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Nucleic Acid Isolation and Purification Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Nucleic Acid Isolation and Purification Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Nucleic Acid Isolation and Purification Market:
• Qiagen N.V.
• Thermo Fisher Scientific
• F. Hoffman-la Roche Ag
• Promega Corporation
• Agilent Technologies
• Bio-rad Laboratories
• Danaher Corporation
• GE Healthcare
• Illumina
• Merck KGAA
• Takara Bio, Inc.
• New England Biolabs
• Zymo Research
• Norgen Biotek
• Omega Bio-tek, Inc.
• Genaxxon Bioscience Gmbh
• 3B Blackbio Biotech India Ltd.
• Invitek Molecular Gmbh
• Biovision
• Analytik Jena AG
(Note: The list of the major players will be updated with the latest market scenario and trends)

Nucleic Acid Isolation and Purification Market Segmentation:
By Product 
• Kits
• Reagents
• Instruments
By Type 
• Plasmid DNA Isolation and Purification
• Total RNA Isolation and Purification
• Circulating Nucleic Acid Isolation and Purification
• Genomic DNA Isolation and Purification
• Messenger RNA Isolation and Purification
• microRNA Isolation and Purification
• PCR Cleanup
• Other Nucleic Acid Isolation and Purification Types
By Method
• Column-based Isolation and Purification
• Magnetic Bead-based Isolation and Purification
• Reagent-based Isolation and Purification
• Other Isolation and Purification Methods
By Application
• Diagnostics
• Drug Discovery & Development
• Personalized Medicine
• Agriculture & Animal Research
• Other Applications
By End User
• Hospitals & Diagnostic Centers
• Academic & Government Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Other End Users
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Nucleic Acid Isolation and Purification Market By Product, By Type, By Method, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Offering launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com 

Table of Contents

1. Market Introduction
   1.1 Objectives of the Study 
   1.2 Market Definition 
   1.3 Market Scope 
       1.3.1 Years Considered for the Study
       1.3.2 Market Covered
   1.4 Currency 
   1.5 Limitations 
   1.6 Stakeholders 

2. Research Tracking Typeology 
    2.1 Research Data 
        2.1.1 Secondary Data
              2.1.1.1 Key Data from Secondary Sources
        2.1.2 Primary Data
              2.1.2.1 Key Data from Primary Sources
    2.2 Market Size Estimation 
    2.3 Market Breakdown and Data Triangulation 
    2.4 Assumptions for the Study  

3. Executive Summary
   3.1 Market Outlook
   3.2 Segment Outlook
   3.3 Competitive Insights

4. Global Nucleic Acid Isolation and Purification Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Nucleic Acid Isolation and Purification Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Nucleic Acid Isolation and Purification Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Global Nucleic Acid Isolation and Purification Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
   7.1. Kits
   7.2. Reagents
   7.3. Instruments

8. Global Nucleic Acid Isolation and Purification Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)  
   8.1. Plasmid DNA Isolation and Purification
   8.2. Total RNA Isolation and Purification
   8.3. Circulating Nucleic Acid Isolation and Purification
   8.4. Genomic DNA Isolation and Purification
   8.5. Messenger RNA Isolation and Purification
   8.6. microRNA Isolation and Purification
   8.7. PCR Cleanup
   8.8. Other Nucleic Acid Isolation and Purification Types
        
9. Global Nucleic Acid Isolation and Purification Market, By Method Historical Analysis and Forecast 2020-2027 (USD Million)  
   9.1. Column-based Isolation and Purification
   9.2. Magnetic Bead-based Isolation and Purification
   9.3. Reagent-based Isolation and Purification
   9.4. Other Isolation and Purification Methods    

10. Global Nucleic Acid Isolation and Purification Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)  
    10.1. Diagnostics
    10.2. Drug Discovery & Development
    10.3. Personalized Medicine
    10.4. Agriculture & Animal Research
    10.5. Other Applications

11. Global Nucleic Acid Isolation and Purification Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)  
    11.1. Hospitals & Diagnostic Centers
    11.2. Academic & Government Research Institutes
    11.3. Pharmaceutical & Biotechnology Companies
    11.4. Contract Research Organizations
    11.5. Other End Users

12. North America Nucleic Acid Isolation and Purification Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
        12.2.1. U.S.A
        12.2.2. Canada
        12.2.3. Mexico
   12.3. Market Size (USD Million) Forecast for North America 2020-2027

13. Latin America Nucleic Acid Isolation and Purification Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          13.2.1. Brazil
          13.2.2. Venezuela
          13.2.3. Argentina
          13.2.4. Rest of Latin America
    13.3. Market Size (USD Million) Forecast for Latin America 2020-2027

14. Europe Nucleic Acid Isolation and Purification Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          14.2.1. Germany
          14.2.2. U.K         
          14.2.3. France
          14.2.4. Italy
          14.2.5. Spain
          14.2.6. Russia
          14.2.7. Poland
          14.2.8. Rest of Europe
    14.3. Market Size (USD Million) Forecast for Europe 2020-2027

15. Asia Pacific Nucleic Acid Isolation and Purification Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          15.2.1. Japan
          15.2.2. China
          15.2.3. India
          15.2.4. Australia and New Zealand
          15.2.5. ASEAN
          15.2.6. Rest of Asia Pacific
    15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          16.2.1. Saudi Arabia
          16.2.2. UAE
          16.2.3. South Africa
          16.2.4. Egypt
    16.3. Market Size (USD Million) Forecast for MEA 2020-2027

17. Market Share Analysis and Competitive Landscape   
    17.1. Global Landscape - Key Players, Revenue and Presence
    17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    17.3. Global Emerging Companies
    17.4.  North America - Market Share Analysis and Key Regional Players
    17.5.  Europe - Market Share Analysis and Key Regional Players
    17.6.  Asia Pacific - Market Share Analysis and Key Regional Players
    17.7.  Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Offerings Offered and Financial Layouts)
    18.1. Qiagen N.V.
          18.1.1. Company Overview
          18.1.2. Product Portfolio
          18.1.3. SWOT Analysis
          18.1.4. Financial Overview
          18.1.5. Strategic Overview
    18.2. Thermo Fisher Scientific
          18.2.1. Company Overview
          18.2.2. Product Portfolio
          18.2.3. SWOT Analysis
          18.2.4. Financial Overview
          18.2.5. Strategic Overview 
    18.3. F. Hoffman-la Roche AG
          18.3.1. Company Overview
          18.3.2. Product Portfolio
          18.3.3. SWOT Analysis
          18.3.4. Financial Overview
          18.3.5. Strategic Overview
    18.4. Promega Corporation
          18.4.1. Company Overview
          18.4.2. Product Portfolio
          18.4.3. SWOT Analysis
          18.4.4. Financial Overview
          18.4.5. Strategic Overview
    18.5. Agilent Technologies
          18.5.1. Company Overview
          18.5.2. Product Portfolio
          18.5.3. SWOT Analysis
          18.5.4. Financial Overview
          18.5.5. Strategic Overview          
    18.6. Bio-rad Laboratories
          18.6.1. Company Overview
          18.6.2. Product Portfolio
          18.6.3. SWOT Analysis
          18.6.4. Financial Overview
          18.6.5. Strategic Overview      
    18.7. Danaher Corporation
          18.7.1. Company Overview
          18.7.2. Product Portfolio
          18.7.3. SWOT Analysis
          18.7.4. Financial Overview
          18.7.5. Strategic Overview
    18.8. GE Healthcare
          18.8.1. Company Overview
          18.8.2. Product Portfolio
          18.8.3. SWOT Analysis
          18.8.4. Financial Overview
          18.8.5. Strategic Overview 
    18.9. Illumina
          18.9.1. Company Overview
          18.9.2. Product Portfolio
          18.9.3. SWOT Analysis
          18.9.4. Financial Overview
          18.9.5. Strategic Overview 
    18.10. Merck KGAA
          18.10.1. Company Overview
          18.10.2. Product Portfolio
          18.10.3. SWOT Analysis
          18.10.4. Financial Overview
          18.10.5. Strategic Overview 
    18.11. Takara Bio, Inc.
          18.11.1. Company Overview
          18.11.2. Product Portfolio
          18.11.3. SWOT Analysis
          18.11.4. Financial Overview
          18.11.5. Strategic Overview 
    18.12. New England Biolabs
          18.12.1. Company Overview
          18.12.2. Product Portfolio
          18.12.3. SWOT Analysis
          18.12.4. Financial Overview
          18.12.5. Strategic Overview 
    18.13. Zymo Research
          18.13.1. Company Overview
          18.13.2. Product Portfolio
          18.13.3. SWOT Analysis
          18.13.4. Financial Overview
          18.13.5. Strategic Overview 
    18.14. Norgen Biotek
          18.14.1. Company Overview
          18.14.2. Product Portfolio
          18.14.3. SWOT Analysis
          18.14.4. Financial Overview
          18.14.5. Strategic Overview 
    18.15. Omega Bio-tek, Inc.
          18.15.1. Company Overview
          18.15.2. Product Portfolio
          18.15.3. SWOT Analysis
          18.15.4. Financial Overview
          18.15.5. Strategic Overview 
    18.16. Genaxxon Bioscience Gmbh
          18.16.1. Company Overview
          18.16.2. Product Portfolio
          18.16.3. SWOT Analysis
          18.16.4. Financial Overview
          18.16.5. Strategic Overview 
    18.17. 3B Blackbio Biotech India Ltd.
          18.17.1. Company Overview
          18.16.2. Product Portfolio
          18.16.3. SWOT Analysis
          18.16.4. Financial Overview
          18.16.5. Strategic Overview 
    18.18. Invitek Molecular Gmbh
          18.18.1. Company Overview
          18.18.2. Product Portfolio
          18.18.3. SWOT Analysis
          18.18.4. Financial Overview
          18.18.5. Strategic Overview 
    18.19. Biovision
          18.19.1. Company Overview
          18.19.2. Product Portfolio
          18.19.3. SWOT Analysis
          18.19.4. Financial Overview
          18.19.5. Strategic Overview 
    18.20. Analytik Jena AG
          18.20.1. Company Overview
          18.20.2. Product Portfolio
          18.20.3. SWOT Analysis
          18.20.4. Financial Overview
          18.20.5. Strategic Overview 
   
19. Pre and Post COVID-19 Impact
    19.1. Positive influence on the healthcare industry
    19.2. The financial disruption of the manufacturing sector
    19.3. Impact of COVID-19 on emerging companies
    19.4. Significant mandates in the healthcare regulations initiated by administrations
    19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures